ZFPM2-ANXA13 Fusion FISH Probe
The ZFPM2-ANXA13 Fusion FISH Probe is used to confirm a fusion of the ZFPM2 and ANXA13 genes. The fusion of the ZFPM2 and ANXA13 genes has been associated with Head And Neck Squamous Cell Carcinoma . These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| ZFPM2-ANXA13-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| ZFPM2-ANXA13-20-RERE | 20 (40 μL) | 200 μL |
|
|
| ZFPM2-ANXA13-20-REOR | 20 (40 μL) | 200 μL |
|
|
| ZFPM2-ANXA13-20-REGO | 20 (40 μL) | 200 μL |
|
|
| ZFPM2-ANXA13-20-REGR | 20 (40 μL) | 200 μL |
|
|
| ZFPM2-ANXA13-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| ZFPM2-ANXA13-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| ZFPM2-ANXA13-20-OROR | 20 (40 μL) | 200 μL |
|
|
| ZFPM2-ANXA13-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| ZFPM2-ANXA13-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| ZFPM2-ANXA13-20-GORE | 20 (40 μL) | 200 μL |
|
|
| ZFPM2-ANXA13-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| ZFPM2-ANXA13-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| ZFPM2-ANXA13-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| ZFPM2-ANXA13-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| ZFPM2-ANXA13-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| ZFPM2-ANXA13-20-GROR | 20 (40 μL) | 200 μL |
|
|
| ZFPM2-ANXA13-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| ZFPM2-ANXA13-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| ZFPM2-ANXA13-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| ZFPM2-ANXA13-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| ZFPM2-ANXA13-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| ZFPM2-ANXA13-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| ZFPM2-ANXA13-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| ZFPM2-ANXA13-20-AQAQ | 20 (40 μL) | 200 μL |
|
ANXA13 Gene Summary
This gene encodes a member of the annexin family. Members of this calcium-dependent phospholipid-binding protein family play a role in the regulation of cellular growth and in signal transduction pathways. The specific function of this gene has not yet been determined; however, it is associated with the plasma membrane of undifferentiated, proliferating endothelial cells and differentiated villus enterocytes. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
Gene Name: Annexin A13
Chromosome: CHR8: 124693033 -124749647
Locus: 8q24.13
ZFPM2 Gene Summary
The zinc finger protein encoded by this gene is a widely expressed member of the FOG family of transcription factors. The family members modulate the activity of GATA family proteins, which are important regulators of hematopoiesis and cardiogenesis in mammals. It has been demonstrated that the protein can both activate and down-regulate expression of GATA-target genes, suggesting different modulation in different promoter contexts. A related mRNA suggests an alternatively spliced product but this information is not yet fully supported by the sequence. [provided by RefSeq, Jul 2008]
Gene Name: Zinc Finger Protein, FOG Family Member 2
Chromosome: CHR8: 106331146 -106816767
Locus: 8q23.1
Gene Diseases
The ZFPM2 ANXA13 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Head And Neck Squamous Cell Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|